FDA-Drug2020-07-01Class III
R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804, NDC 70092143350
QuVa Pharma, Inc.
Hazard
Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
Sold states
Distributed Nationwide in the US.
Affected count
17,050 syringes
Manufactured in
1075 W Park One Dr Ste 100, N/A, Sugar Land, TX, United States
Products
R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804, NDC 70092143350
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1335-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief